Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Balance Sheet
Balance Sheet Decomposition
Deciphera Pharmaceuticals Inc
Current Assets | 349.9m |
Cash & Short-Term Investments | 272.5m |
Receivables | 32.7m |
Other Current Assets | 44.7m |
Non-Current Assets | 71m |
Long-Term Investments | 26.8m |
PP&E | 36.1m |
Other Non-Current Assets | 8.1m |
Current Liabilities | 83.4m |
Accounts Payable | 19.5m |
Accrued Liabilities | 34.7m |
Other Current Liabilities | 29.3m |
Non-Current Liabilities | 21.4m |
Other Non-Current Liabilities | 21.4m |
Balance Sheet
Deciphera Pharmaceuticals Inc
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash & Cash Equivalents |
26
|
57
|
197
|
294
|
120
|
106
|
87
|
65
|
84
|
|
Cash Equivalents |
26
|
57
|
197
|
294
|
120
|
106
|
87
|
65
|
84
|
|
Short-Term Investments |
0
|
0
|
0
|
0
|
459
|
446
|
199
|
260
|
223
|
|
Total Receivables |
0
|
0
|
0
|
0
|
0
|
14
|
21
|
22
|
32
|
|
Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
14
|
21
|
22
|
32
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
6
|
14
|
21
|
21
|
|
Other Current Assets |
1
|
1
|
1
|
7
|
14
|
12
|
19
|
25
|
22
|
|
Total Current Assets |
26
|
58
|
198
|
301
|
593
|
584
|
339
|
393
|
381
|
|
PP&E Net |
0
|
1
|
1
|
13
|
27
|
46
|
45
|
43
|
37
|
|
PP&E Gross |
0
|
1
|
1
|
13
|
27
|
46
|
45
|
43
|
37
|
|
Accumulated Depreciation |
1
|
1
|
1
|
1
|
2
|
4
|
7
|
10
|
12
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
9
|
42
|
15
|
47
|
|
Other Long-Term Assets |
0
|
0
|
0
|
1
|
2
|
3
|
3
|
3
|
8
|
|
Total Assets |
27
N/A
|
59
+120%
|
199
+238%
|
316
+58%
|
622
+97%
|
642
+3%
|
429
-33%
|
454
+6%
|
474
+4%
|
|
Liabilities | ||||||||||
Accounts Payable |
2
|
1
|
4
|
8
|
20
|
12
|
13
|
19
|
26
|
|
Accrued Liabilities |
1
|
3
|
9
|
14
|
40
|
54
|
54
|
51
|
48
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
30
|
17
|
26
|
|
Total Current Liabilities |
3
|
5
|
14
|
23
|
60
|
70
|
97
|
86
|
100
|
|
Long-Term Debt |
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
0
|
0
|
0
|
12
|
16
|
29
|
28
|
26
|
22
|
|
Total Liabilities |
5
N/A
|
6
+28%
|
15
+150%
|
36
+135%
|
76
+113%
|
99
+30%
|
125
+26%
|
112
-10%
|
123
+9%
|
|
Equity | ||||||||||
Common Stock |
137
|
193
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Retained Earnings |
120
|
146
|
196
|
296
|
488
|
754
|
1 054
|
1 233
|
1 428
|
|
Additional Paid In Capital |
4
|
6
|
380
|
575
|
1 034
|
1 298
|
1 359
|
1 575
|
1 778
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
Total Equity |
22
N/A
|
53
+140%
|
184
+248%
|
280
+52%
|
546
+95%
|
544
-1%
|
305
-44%
|
342
+12%
|
351
+3%
|
|
Total Liabilities & Equity |
27
N/A
|
59
+120%
|
199
+238%
|
316
+58%
|
622
+97%
|
642
+3%
|
429
-33%
|
454
+6%
|
474
+4%
|
|
Shares Outstanding | ||||||||||
Common Shares Outstanding |
31
|
31
|
33
|
38
|
52
|
58
|
59
|
68
|
81
|